4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) CEO David Kirn Sells 12,930 Shares
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) CEO David Kirn sold 12,930 shares of the business’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $23.10, for a total transaction of $298,683.00. Following the transaction, the chief executive officer now owns 1,059,153 shares in the […]
More Stories
Brokerages Set HEICO Co. (NYSE:HEI) Target Price at $236.00
Shares of HEICO Co. (NYSE:HEI – Get Free Report) have received an average rating of “Moderate Buy” from the nine...
Newmont Co. (NYSE:NEM) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Newmont Co. (NYSE:NEM – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen...
STMicroelectronics (NYSE:STM) Given Average Rating of “Moderate Buy” by Analysts
Shares of STMicroelectronics (NYSE:STM – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven...
Globus Medical, Inc. (NYSE:GMED) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of Globus Medical, Inc. (NYSE:GMED – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from...
London Stock Exchange Group plc (LON:LSEG) Given Consensus Recommendation of “Buy” by Analysts
Shares of London Stock Exchange Group plc (LON:LSEG – Get Free Report) have been assigned an average rating of “Buy”...
Short Interest in Hillenbrand, Inc. (NYSE:HI) Grows By 16.7%
Hillenbrand, Inc. (NYSE:HI – Get Free Report) was the recipient of a significant increase in short interest in June. As...